No Data
Hao Chen Healthcare: Report for the third quarter of 2024
A-shares surged against the trend in the private hospital concept, and Whole Shine Medical Technology hit the limit.
On September 9th, Whole Shine Medical Technology and Jiangsu Aoyang Health Industry both hit the daily limit, while Inkon Life Technology, Everjoy Health Group, Xi'an International Medical Investment, and New Journey Health Technology Group followed the upward trend. In terms of news, the Ministry of Commerce and two other departments recently issued a notice regarding the expansion of pilot projects in the medical field, proposing to allow the establishment of wholly foreign-owned hospitals (excluding traditional Chinese medicine, excluding the acquisition of public hospitals) in Beijing, Tianjin, Shanghai, Nanjing, Suzhou, Fuzhou, Guangzhou, Shenzhen, and the entire Hainan Island.
Hao Chen Healthcare: 2024 Semi-Annual Report
Hao Chen Healthcare: 2024 Semi-Annual Report Summary
Whole Shine Medical Technology (002622.SZ): net income of 0.5535 million yuan in the first half of the year, a year-on-year decrease of 92.74%.
Gelonghui August 29th | Whole Shine Medical Technology (002622.SZ) released the 2024 interim report, with revenue of 0.382 billion yuan for the reporting period, a year-on-year increase of 21.80%; net income attributable to shareholders of listed companies was 0.5535 million yuan, a year-on-year decrease of 92.74%; net income attributable to shareholders of listed companies after deducting non-recurring gains and losses was 0.1691 million yuan, a year-on-year decrease of 97.08%; basic earnings per share was 0.0007 yuan.
Whole Shine Medical Technology (002622.SZ) released its semi-annual performance, with a net income of 0.5535 million yuan, a year-on-year decrease of 92.74%.
Whole Shine Medical Technology (002622.SZ) released the 2024 interim report, with a revenue of 3...
No Data
No Data